Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
Interpreting cost analyses of clinical interventions. [electronic resource] by
- Balas, E A
- Kretschmer, R A
- Gnann, W
- West, D A
- Boren, S A
- Centor, R M
- Nerlich, M
- Gupta, M
- West, T D
- Soderstrom, N S
Producer: 19980115
In:
JAMA vol. 279
Availability: No items available.
|
|
33.
|
A solid phase extraction-liquid chromatographic-tandem mass spectrometry method for determination of concentrations of GDC-0941, a small molecule class I phosphatidylinositide 3-kinase inhibitor, to support clinical development. [electronic resource] by
- Ding, X
- Morrison, G
- Dean, B
- Hop, C E C A
- Tobler, L
- Percey, S
- Meng, M
- Reuschel, S
- West, D A
- Holden, S
- Ware, J A
Producer: 20120928
In:
Journal of pharmaceutical and biomedical analysis vol. 61
Availability: No items available.
|